StockData
AN2 Therapeutics, Inc. logo

AN2 Therapeutics, Inc. (ANTX) stock

ANTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$4.23−0.24 (-5.37%)

Close on Nov 17, 2026Market cap $159.62MP/E –Yield –

AN2 Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

AN2 Therapeutics's market cap was $161.94M on Nov 11, 2026, against $29.83M a year earlier. Over the last 5 years it ranged from $29.83M to $609.40M, with a median of $108.98M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$161.94M+419.0%
2025Dec 31, 2025$31.20M-24.3%
2024Dec 31, 2024$41.22M-93.2%
2023Dec 29, 2023$609.40M+229.6%
2022Dec 30, 2022$184.91M–

More AN2 Therapeutics figures

See a number that looks wrong?